The approved oral semaglutide tablet is $149 at starter doses and $299 at maintenance
Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
The manufacturer's own price guide sets two tiers. The $149 rate on the 4 mg dose ends 31 August 2026.
Read on the manufacturer's published price guide on 4 August 2026:
- Tablet, 1.5 and 4 mg — $149. The 4 mg price rises to $199 after 31 August 2026.
- Tablet, 9 and 25 mg — $299. These are the maintenance doses.
- Pen, new-patient intro — $199 for the first two fills, to 31 December 2026, then $349.
- Pen, 0.25–2.4 mg — $349. Higher-dose 7.2 mg pen — $399.
- With commercial cover, the savings offer reaches as little as $25, capped at $100 a month in savings.
Any page quoting a flat $149 for the approved pill is quoting a starter-dose figure as the price of treatment. We corrected our own reporting of this — COR-003.
Filed by the Transparent Peptide research desk. Corrections: the corrections log.